Clinical trials

  • AMG 732 for Thyroid Eye Disease | Graves' ophthalmopathy
  • JNJ-80948543 (and other CD3 TCEs) for Relapsed/Refractory B-cell Non-Hodgkin lymphoma | Non-Hodgkin's lymphoma
  • ENCORAFENIB for Colon cancer (BRAF V600E-mutated, localized)|Upper rectum cancer (BRAF V600E-mutated, localized)
  • tezacaftor, deutivacaftor, vanzacaftor for Cystic fibrosis
  • METHYL AMINOLEVULINATE for Extra-mammary Paget disease of the vulva
  • metyrapone for Mild autonomous cortisol secretion
  • TILT-123 for Melanoma
  • RAPCABTAGENE AUTOLEUCEL for Idiopathic inflammatory myopathies (severe refractory) | Immune-mediated myositis
  • INDOCYANINE GREEN for Pulmonary metastases | Rhabdomyosarcoma | Non-rhabdomyosarcoma soft tissue sarcoma | Neuroblastoma | Germ cell tumour | Renal tumour | Paratesticular rhabdomyosarcoma
  • IPH4502 for Advanced Solid Tumors
  • MIRVETUXIMAB SORAVTANSINE for Ovarian cancer (recurrent) | Fallopian tube cancer | Peritoneal carcinoma
  • DEXAMETHASONE for Multiple myeloma